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increase with increased cardiac output (and/or stroke volume)
(3,4). Such IVUS imaging (Fig. 5A) does not correspond to the
ostium, as noted in the legend, but to a more distal segment inside
the wall of the aorta: an injection of saline/microbubbles in the
aorta by the guiding catheter at the aortic root would have made it
more obvious. The ostium in such cases is expected to be
tangential, with a typical half-moon appearance on IVUS (3,4).
The aforementioned issue of hypoplasia is a fundamental one in
such context, because it appears that intramural coronary arteries do
not grow as normal with ageing during the first 20 years of life (this
is different from the so-called Glacov phenomenon, associated with
later atherosclerosis). Incidentally, our IVUS finding in similar pa-
tients carrying intussuscepted coronary arteries (currently, more than
30 cases at our institution) suggests that these coronary segments are
protected both for atherosclerotic buildup and calcifications (which is
quite obvious while studying older diabetic patients) (3,4).
The reported intimal thickening of 6.4  5.7% of the vessel’s
lumen (1) may not actually be due to atherosclerosis, but to self-
limited fibrous scarring related to surgery, as suggested by the fact that
it does not progress with years of follow up.
We encourage Pedra et al. (1) and other investigators of such
delicate subject to study all of their postoperative patients with
IVUS (and not only the technically easy ones), while being aware
of the afore-mentioned methodological issues. In particular, ec-
topic vessels with tangential origin frequently cause great difficul-
ties of cannulation, but they are the most important cases to be
studied! The issue of the normal size of a coronary artery (and of
the diagnosis of hypoplasia) is a basic one. We have conceded the
difficulty of such evaluation, while establishing the normal refer-
ence lumen in cases of intussuscepted coronary arteries in adults,
by assuming that the distal vessel has generally normal cross
section (3,4).
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REPLY
We appreciate Dr. Angelini’s interest in our study (1), and we
thank him for his comments. Our study was part of larger
project in which left ventricular function was also evaluated late
after the arterial switch operation (ASO) using rest and stress
two-dimensional echocardiography. The minimum follow-up
period of five years after the operation was chosen arbitrarily,
and because the two-stage operation might have a deleterious
impact on ventricular function, those patients managed by this
approach were excluded. Although almost 300 children have
been operated on for transposition of the great arteries (TGA)
at our institution, only a third were candidates for the study
based on the inclusion and exclusion criteria. Because of TGA
the referral nature of our institution and the continental size of
our country, a significant number of patients were lost to
follow-up. In addition, many patients who were contacted
refused to participate in the protocol because they had been
doing well. This explains why only 22 patients were eventually
enrolled. As such, we agree with Dr. Angelini that this may not
be a representative sample of the whole series of patients.
However, because the intravascular ultrasound (IVUS) findings
in our study were very similar for the entire cohort (1), it is
unlikely that all patients who were not enrolled had dissimilar
IVUS findings.
The fact that IVUS could not be performed in two children
does not mean that we only performed the technically easy cases.
We simply took a safer approach; it would have been hard to justify
any complications associated with technical difficulties in a
symptom-free population, especially considering that the use of
IVUS for coronary assessment late after the ASO for TGA is a
delicate subject, as Dr. Angelini correctly pointed out in his letter.
Although the arguments presented by Dr. Angelini were very
interesting, we disagree that our Figure 5A (1) represents an
intramural coronary segment. Indeed, an intramural coronary
artery may be occasionally found in neonates with TGA, posing
technical difficulties to transfer the aortocoronary flap to the
neoaorta and increasing the surgical risks (2). However, none of
the patients in our series had this anatomical pattern at the
operation. In addition, real-time cross-sectional IVUS imaging in
that patient did not show any phasic compression or a half-moon
appearance of the ostium. In fact, the ostium possessed an elliptical
configuration, which had a cross-sectional area very similar to the
adjacent distal coronary segment.
Acquired compression, torsion, and stretching of the proximal
coronary arteries certainly occur after the ASO. In fact, these
lesions are associated with early coronary events after a technically
difficult operation, as shown by Legendre et al. (3). Late coronary
events, albeit uncommon, are unlikely to be explained on the same
grounds. In their series, Legendre et al. (3) reported a patient who
had a normal coronary angiogram and eventually developed a late
coronary artery obstruction, indicating that there are other mech-
anisms involved in late obstructions. The observation that most of
the studied vessels in our series had proximal eccentric intimal
thickening suggests the development of early atherosclerosis in the
reimplanted coronary arteries (1), which may have a role in the
genesis of late coronary events. Severe intracoronary fibrous pro-
liferation may occur after the ASO, resulting in infarction and
death (4).
At the moment, no matter what mechanism is involved, there is
not enough evidence to state that these abnormalities are self-
limited and do not progress with time. In fact, we would rather
take a more cautious approach, highlighting the need to develop
strategies to control risk factors for coronary artery disease in the
late follow-up of these patients.
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Microvolt T-Wave Alternans:
Where Do We Go From Here?
The recent meta-analysis by Gehi et al. (1) assessed the value of
microvolt T-wave alternans (MTWA) testing to predict cardiac
arrhythmic events in differing patient populations. Their analyses
provide a summary estimate of the predictive value of MTWA in
patients with ischemic and non-ischemic cardiomyopathy. In their
discussion, the investigators point out that while MTWA has
shown promise in identifying high-risk patients, studies have been
hampered by small sample sizes. Importantly, this has limited the
comparisons of baseline characteristics between individuals with
negative and non-negative MTWA tests in most studies and has
prevented adequate multivariable adjustment for potential con-
founders.
This raises questions as to whether MTWA is simply a
surrogate marker of patients with greater disease burden and
severity. If so, differences in age, left ventricular ejection fraction
(LVEF), clinical comorbidities, and medication treatment between
individuals with negative and non-negative MTWA tests may
explain its predictive power. We believe that in order for MTWA
to gain wider acceptance as a risk stratification tool, three types of
analyses are needed. First, multivariable modeling that adjusts for
demographics, LVEF, clinical comorbidities, medication treatment,
as well as electrophysiologic variables (e.g., Holter monitoring, QRS
duration, electrophysiologic study) should be done to show that
MTWA is an independent predictor of cardiac arrhythmias. Gehi et al.
(1) themselves acknowledge that MTWA does not offer incremental
prognostic utility unless it can be shown to add predictive power
beyond known risk factors for cardiac arrhythmia (such as LVEF in
patients with ischemic cardiomyopathy).
Second, studies of MTWA should provide analyses of
all-cause mortality in addition to arrhythmic mortality. Prior
studies of MTWA that used a primary end point of cardiac
arrhythmic events may be limited as they did not consider
competing risks whereby MTWA may predict arrhythmic, but
not all-cause, mortality.
Finally, even if future studies demonstrate that MTWA offers
incremental prognostic utility in assessing high-risk patients, its
true utility for risk stratification will only be known when the
mortality reduction benefit of implantable cardioverter-defibrillators
(ICDs) is evaluated in patients who test MTWA-negative and
non-negative. This could be accomplished by randomizing patients to
ICD therapy after MTWA testing, but such a clinical trial might
raise ethical concerns given that some high-risk patients may be
denied life-saving therapy. To justify such a clinical trial, additional
cohort analysis using propensity scores for ICD therapy based on
MTWA status may be needed (2).
Gehi et al. (1) are to be commended for their synthesis of a large
pool of clinical data on MTWA. Future studies of MTWA should
focus on its incremental prognostic utility after multivariable
adjustment, but ultimately the true utility of MTWA in risk-
stratifying high-risk patients will remain uncertain unless it can be
shown that the benefit of ICDs differs by MTWA subgroup.
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REPLY
We appreciate the thoughtful comments of Dr. Chan and col-
leagues regarding our meta-analysis of microvolt T-wave alternans
(MTWA) and wish to expand upon several points (1).
As dicussed by Dr. Chan and colleagues and as we pointed out
in our Discussion section, very few studies have demonstrated
whether MTWA is predictive of future arrhythmic events inde-
pendent of other well-established clinical predictors. There is
substantial evidence regarding the prognostic utility of other risk
predictors, including ejection fraction (EF), signal-averaged elec-
trocardiogram (ECG), heart rate variability, electrophysiologic
study, and baroreflex sensitivity. Though MTWA may be the test
currently in vogue, until MTWA is shown to add substantial
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